Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts
- 1 September 1998
- journal article
- research article
- Published by Springer Nature in Springer Seminars in Immunopathology
- Vol. 20 (3-4) , 455-491
- https://doi.org/10.1007/bf00838055
Abstract
No abstract availableKeywords
This publication has 251 references indexed in Scilit:
- Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex‐bound peptide by T cells and its role in alloreactivityEuropean Journal of Immunology, 1997
- Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the epstein‐barr virus latent antigen EBNA‐4International Journal of Cancer, 1995
- Donor T Cells to Treat EBV-Associated LymphomaNew England Journal of Medicine, 1994
- Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative DiseaseNew England Journal of Medicine, 1989
- Restriction of Epstein-Barr virus-specific cytotoxic T cells by HLA-A, -B, and -C moleculesHuman Immunology, 1989
- The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replicationCell, 1989
- Non-Hodgkin's Lymphoma in 90 Homosexual MenNew England Journal of Medicine, 1984
- Epstein–Barr Virus Replication in Oropharyngeal Epithelial CellsNew England Journal of Medicine, 1984
- Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious MononucleosisNew England Journal of Medicine, 1979
- Quantitative Evaluation of Epstein-Barr-Virus-Infected Mononuclear Peripheral Blood Leukocytes in Infectious MononucleosisNew England Journal of Medicine, 1977